1887

Abstract

Growing concern about the increasing frequency of resistance of to the available antimicrobial agents worldwide has encouraged the search for new strategies in treating and eradicating infections. Endoscopic blue-light therapy has been used in patients with gastritis with limited success due to subsequent repopulation with . Clinical trials using Curcumin could not eradicate infection either.

We studied the effect of blue light emitting diodes (LEDs) in conjunction with Curcumin on , since this has not been previously reported.

We examined the effect of Curcumin with and without irradiation with blue LEDs on the viability of and four key factors important for colonization and establishment of infection, namely urease production, motility, adhesion and biofilm formation.

We found that a combination of Curcumin and blue LEDs caused significant reductions in viability, urease production, motility, haemagglutination activity, as well as increased disruption of mature preformed biofilms of , in comparison to Curcumin alone (<0.0001), at sublethal concentrations of Curcumin.

Targeting the virulence factors of with blue LED photoactivated Curcumin would theoretically cripple this pathogen from colonizing and causing tissue damage and perhaps overcome the problem of repopulation with that often occurs following endoscopic blue-light therapy.

Funding
This study was supported by the:
  • Homa Darmani , Jordan University of Science and Technology , (Award 20150257)
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001168
2020-02-25
2020-06-03
Loading full text...

Full text loading...

/deliver/fulltext/jmm/69/4/617.html?itemId=/content/journal/jmm/10.1099/jmm.0.001168&mimeType=html&fmt=ahah

References

  1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10:720–741 [CrossRef][PubMed]
    [Google Scholar]
  2. Lacy BE, Rosemore J. Helicobacter pylori: ulcers and more: the beginning of an era. J Nutr 2001; 131:2789S–2793 [CrossRef]
    [Google Scholar]
  3. Rowland M, Daly L, Vaughan M, Higgins A, Bourke B et al. Age-Specific incidence of Helicobacter pylori . Gastroenterology 2006; 130:65–72 [CrossRef]
    [Google Scholar]
  4. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 321:1273–1275
    [Google Scholar]
  5. Wessler S, Krisch LM, Elmer DP, Aberger F. From inflammation to gastric cancer – the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal 2017; 15:15 [CrossRef]
    [Google Scholar]
  6. O'Morain NR, Dore MP, O'Connor AJP, Gisbert JP, O'Morain CA. Treatment of Helicobacter pylori infection in 2018. Helicobacter 2018; 23:e12519 [CrossRef]
    [Google Scholar]
  7. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 2009; 53:1592–1597 [CrossRef]
    [Google Scholar]
  8. Ma J, Hiratsuka T, Etoh T, Akada J, Fujishima H et al. Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori . J Gastroenterol Hepatol 2018; 33:1492–1499 [CrossRef]
    [Google Scholar]
  9. Ganz RA, Viveiros J, Ahmad A, Ahmadi A, Khalil A et al. Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005; 36:260–265 [CrossRef]
    [Google Scholar]
  10. Lembo AJ, Ganz RA, Sheth S, Cave D, Kelly C et al. Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: A pilot clinical trial. Lasers Surg Med 2009; 41:337–344 [CrossRef]
    [Google Scholar]
  11. Kewitz S, Volkmer I, Staege MS. Curcuma contra cancer? Curcumin and Hodgkin's lymphoma. Cancer Growth Metastasis 2013; 6:CGM.S11113–.11152 [CrossRef]
    [Google Scholar]
  12. Liu Y, Wang X, Zeng S, Zhang X, Zhao J et al. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2018; 37:303 [CrossRef]
    [Google Scholar]
  13. Weseler A, Geiss HK, Saller R, Reichling J. A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori . Pharmazie 2005; 60:498–502
    [Google Scholar]
  14. Yonezawa H, Osaki T, Kurata S, Fukuda M, Kawakami H et al. Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation. BMC Microbiol 2009; 9:197 [CrossRef]
    [Google Scholar]
  15. Hu Y, Zhu Y, Lu N-H. Novel and effective therapeutic regimens for Helicobacter pylori in an Era of increasing antibiotic resistance. Front Cell Infect Microbiol 2017; 7:168 [CrossRef][PubMed]
    [Google Scholar]
  16. Kao C-Y, Sheu B-S, Wu J-J. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomed J 2016; 39:14–23 [CrossRef][PubMed]
    [Google Scholar]
  17. Alarcón de la Lastra C. Curcumin: a promising spice for therapeutics. Mol Nutr Food Res 2008; 52:985 [CrossRef]
    [Google Scholar]
  18. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 2008; 76:1590–1611 [CrossRef]
    [Google Scholar]
  19. Rai D, Singh JK, Roy N, Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 2008; 410:147–155 [CrossRef]
    [Google Scholar]
  20. Chen C, Johnston TD, Jeon H, Gedaly R, McHugh PP et al. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 2009; 366:133–139 [CrossRef]
    [Google Scholar]
  21. Montopoli M, Ragazzi E, Froldi G, Caparrotta L. Cell-Cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Prolif 2009; 42:195–206 [CrossRef]
    [Google Scholar]
  22. Hamblin MR, Viveiros J, Yang C, Ahmadi A, Ganz RA et al. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 2005; 49:2822–2827 [CrossRef]
    [Google Scholar]
  23. Bauerfeind P, Garner R, Dunn BE, Mobley HL. Synthesis and activity of Helicobacter pylori urease and catalase at low pH. Gut 1997; 40:25–30 [CrossRef]
    [Google Scholar]
  24. Eaton KA, Brooks CL, Morgan DR, Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59:2470–2475 [CrossRef]
    [Google Scholar]
  25. Tarsia C, Danielli A, Florini F, Cinelli P, Ciurli S et al. Targeting Helicobacter pylori urease activity and maturation: In-cell high-throughput approach for drug discovery. Biochim Biophys Acta Gen Subj 2018; 1862:2245–2253 [CrossRef][PubMed]
    [Google Scholar]
  26. Celli JP, Turner BS, Afdhal NH, Keates S, Ghiran I et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. Proc Natl Acad Sci U S A 2009; 106:14321–14326 [CrossRef]
    [Google Scholar]
  27. Wadhams GH, Armitage JP. Making sense of it all: bacterial chemotaxis. Nat Rev Mol Cell Biol 2004; 5:1024–1037 [CrossRef]
    [Google Scholar]
  28. McGee DJ, Langford ML, Watson EL, Carter JE, Chen Y-T et al. Colonization and inflammation deficiencies in Mongolian gerbils infected by Helicobacter pylori chemotaxis mutants. Infect Immun 2005; 73:1820–1827 [CrossRef]
    [Google Scholar]
  29. Williams SM, Chen Y-T, Andermann TM, Carter JE, McGee DJ et al. Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun 2007; 75:3747–3757 [CrossRef]
    [Google Scholar]
  30. Rolig AS, Carter JE, Ottemann KM. Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection. Proc Natl Acad Sci USA 2011; 108:19749–19754 [CrossRef]
    [Google Scholar]
  31. Johnson KS, Ottemann KM. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo . Curr Opin Microbiol 2018; 41:51–57 [CrossRef][PubMed]
    [Google Scholar]
  32. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318–1322 [CrossRef]
    [Google Scholar]
  33. Cammarota G, Sanguinetti M, Gallo A, Posteraro B. Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection. Aliment Pharmacol Ther 2012; 36:222–230 [CrossRef]
    [Google Scholar]
  34. Jensen ET, Kharazmi A, Lam K, Costerton JW, Høiby N. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun 1990; 58:2383–2385 [CrossRef]
    [Google Scholar]
  35. Chen LM, Xu YH, Zhou CL, Zhao J, Li CY et al. Overexpression of Cdr1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations. J Int Med Res 2010; 38:536–545 [CrossRef][PubMed]
    [Google Scholar]
  36. Hobley L, Harkins C, MacPhee CE, Stanley-Wall NR. Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes. FEMS Microbiol Rev 2015; 39:649–669 [CrossRef]
    [Google Scholar]
  37. Koosirirat C, Linpisarn S, Changsom D, Chawansuntati K, Wipasa J. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol 2010; 10:815–818 [CrossRef]
    [Google Scholar]
  38. Judaki A, Rahmani A, Feizi J, Asadollahi K, Hafezi Ahmadi MR. Curcumin in combination with triple therapy regimes ameliorates oxidative stress and histopathologic changes in chronic gastritis-associated Helicobacter pylori infection. Arq Gastroenterol 2017; 54:177–182 [CrossRef]
    [Google Scholar]
  39. Yashavanth HS, Haniadka R, Rao S, Rao P, Alva A. Turmeric and its principal polyphenol curcumin as a nontoxic gastroprotective agent: recent update. In Watson R, Preedy V, Zibadi S. (editors) Polyphenols: Prevention and Treatment of Human Disease London: Elsevier; 2018
    [Google Scholar]
  40. Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155:.e171372–1382 [CrossRef]
    [Google Scholar]
  41. Goosen N, Moolenaar GF. Repair of UV damage in bacteria. DNA Repair 2008; 7:353–379 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001168
Loading
/content/journal/jmm/10.1099/jmm.0.001168
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error